Multiple sclerosis trials in Canada
22 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Vancouver
- Age
- 18 years to 60 years
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - No phaseTaking peopleRepetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis
- Where
- Gatineau
- Age
- 18 years to 70 years
- People
- 70
- Run by
- Clinique Neuro-Outaouais
See details and how to joinNCT07159789 - No phaseTaking peopleDevelopment of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
- Where
- Montreal
- Age
- 18 years and over
- People
- 168
- Run by
- Innodem Neurosciences
See details and how to joinNCT05061953 - Phase 2Taking peopleA Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Where
- Edmonton, Lévis, London, Montreal, Ottawa, Toronto
- Age
- 18 years to 70 years
- People
- 200 worldwide
- Run by
- Celgene
See details and how to joinNCT06782490 - Phase 3Taking peopleEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Where
- Edmonton, Lévis, Montreal, Vancouver
- Age
- 40 years to 70 years
- People
- 400 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00 - Phase 1Taking peopleStudy of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Where
- Montreal, Ottawa
- Age
- 18 years to 75 years
- People
- 57 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07304154 - No phaseNot yet taking people in CanadaAn Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online
- Where
- Toronto
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- University of Melbourne
See details and how to joinNCT07875309 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Burnaby, Calgary, Edmonton, Halifax, Lévis, Montreal, Ottawa, Québec, Sherbrooke, Vancouver
- Age
- 18 years to 65 years
- People
- 1,275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - Phase 1Taking peopleTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Where
- Toronto
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03816345 - Phase 2Taking peopleCannabis (THC vs. CBD) in Multiple Sclerosis
- Where
- Calgary
- Age
- 26 years to 59 years
- People
- 30
- Run by
- University of Calgary
See details and how to joinNCT06261489 - Phase 1Taking peopleAn Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Where
- Montreal
- Age
- 18 years to 60 years
- People
- 24 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07224373 - Phase 4Taking peopleELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
- Where
- Burnaby, Calgary, Edmonton, Halifax, Montreal, Ottawa, Québec, Sherbrooke, St. John's, Vancouver
- Age
- 18 years to 99 years
- People
- 224
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06733922 - Phase 1Not yet taking people in CanadaTranscranial Magnetic Stimulation for Depression in Multiple Sclerosis
- Where
- Calgary
- Age
- 18 years to 65 years
- People
- 20
- Run by
- University of Calgary
See details and how to joinNCT07562074 - No phaseTaking peopleInnovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis
- Where
- Toronto
- Age
- 18 years to 65 years
- People
- 24
- Run by
- University Health Network, Toronto
See details and how to joinNCT07174973 - No phaseTaking peopleImplementation of an App-based Walking Aid Skills Training Program
- Where
- Calgary, Québec
- Age
- 18 years to 99 years
- People
- 52
- Run by
- University of Calgary
See details and how to joinNCT05347875 - Phase 1/2Taking peopleA Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis
- Where
- Toronto
- Age
- 10 years to 25 years
- People
- 20
- Run by
- The Hospital for Sick Children
See details and how to joinNCT04121468 - No phaseNot yet taking people in CanadaExamination of a Self-Compassion Course for Healthcare Providers Working With People With Multiple Sclerosis
- Where
- Toronto
- Age
- 18 years and over
- People
- 40
- Run by
- Robert Simpson
See details and how to joinNCT07097402 - Phase 2Taking peopleCannabis as a Complementary Treatment in Multiple Sclerosis
- Where
- Montreal
- Age
- 21 years and over
- People
- 250
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT05092191 - Phase 1Taking peopleDeep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
- Where
- Sherbrooke
- Age
- 18 years and over
- People
- 6
- Run by
- Université de Sherbrooke
See details and how to joinNCT05451251 - No phaseNot yet taking people in CanadaImplementation of Online Mindfulness-Based Stress Reduction Tailored for People with Multiple Sclerosis
- Where
- Toronto
- Age
- 18 years to 60 years
- People
- 120
- Run by
- Robert Simpson
See details and how to joinNCT06415552 - No phaseTaking peopleEMG Biofeedback Training to Improve Balance in Individuals with Multiple Sclerosis
- Where
- Hamilton
- Age
- 18 years to 80 years
- People
- 46
- Run by
- McMaster University
See details and how to joinNCT06461741 - No phaseNot yet taking people in CanadaRemote Ischemic Conditioning in PPMS
- Where
- Calgary
- Age
- 18 years to 65 years
- People
- 45
- Run by
- University of Calgary
See details and how to joinNCT06171334